Robert Hromas
4Patents
1h-index
11Co-inventors
45Inventor score
Filing activity: Nov 14, 1997 → Apr 14, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6096300A | Treatment of myeloproliferative disease with exodus chemokine | Human Necessities | 14 | Expired |
| US6281200A | Functional characterization of the C-C chemokine-like molecules encoded by molluscum contagiosum virus types 1 and 2 | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11365415B2 | Use of miR-223-3p as a cancer therapeutic and method for treating cancer using the same | Chemistry; Metallurgy | 0 | Active |
| US8889689B2 | Bifunctional metnase/intnase inhibitors and related compositions and methods of treatment of cancer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.